CCND1 GENE AMPLIFICATION

Clinical trials for CCND1 GENE AMPLIFICATION explained in plain language.

Never miss a new study

Get alerted when new CCND1 GENE AMPLIFICATION trials appear

Sign up with your email to follow new studies for CCND1 GENE AMPLIFICATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets advanced breast cancer in First-Ever human trial

Disease control Recruiting now

This is the first human study testing a new oral medication called AVZO-023 for patients with advanced solid tumors, focusing on a common type of breast cancer. The trial aims to find the safest and most effective dose, first by giving AVZO-023 alone, and then in combination with…

Matched conditions: CCND1 GENE AMPLIFICATION

Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control

Last updated Mar 02, 2026 15:21 UTC

CCND1 GENE AMPLIFICATION

Get alerted when new CCND1 GENE AMPLIFICATION trials appear

New pill targets advanced breast cancer in First-Ever human trial